Protein level in blood reveals graft-versus-host disease, may indicate severity of this complication
A new blood test can discern whether a skin rash signals a high-risk complication or just a minor nuisance in people who have undergone a bone marrow transplant, researchers report in the Jan. 6 Science Translational Medicine. The test may also identify early on which patients face long odds and need aggressive treatment for the complication.
As if marrow transplant recipients don’t have enough problems, some patients also develop graft-versus-host disease. In this condition the newly transplanted, or grafted, bon